Search Results - "Bright, EC"

Association of Foxp3 regulatory gene expression with graft-versus-host disease by Miura, Yuji, Thoburn, Christopher J., Bright, Emilie C., Phelps, Michele L., Shin, Tahiro, Matsui, Elizabeth C., Matsui, William H., Arai, Sally, Fuchs, Ephraim J., Vogelsang, Georgia B., Jones, Richard J., Hess, Allan D.

“…Graft-versus-host disease (GVHD) is characterized by an impairment of mechanisms that underlie the development of immunologic tolerance. Although the cytokine…”
Get full text

Cytokine and chemokine profiles in autologous graft-versus-host disease (GVHD): interleukin 10 and interferon γ may be critical mediators for the development of autologous GVHD by Miura, Yuji, Thoburn, Christopher J., Bright, Emilie C., Chen, Weiran, Nakao, Shinji, Hess, Allan D.

“…Administration of the immunosuppressive drug cyclosporine A (CsA) following autologous stem cell transplantation paradoxically elicits a systemic autoimmune…”
Get full text

Functionally divergent T lymphocyte responses induced by modification of a self-peptide from a tumor-associated antigen by Hess, Allan D., Thoburn, Christopher J., Miura, Yuji, Bright, Emilie C.

“…The N- and C-terminal flanking domains of the invariant chain peptide, CLIP, have remarkable immunological properties. Addition of these flanking domains to a…”
Get full text

Characterization of the T-cell repertoire in autologous graft-versus-host disease (GVHD): evidence for the involvement of antigen-driven T-cell response in the development of autologous GVHD by Miura, Yuji, Thoburn, Christopher J., Bright, Emilie C., Sommer, Matthias, Lefell, Susan, Ueda, Mikio, Nakao, Shinji, Hess, Allan D.

“…Administration of cyclosporine A (CsA) after autologous stem cell transplantation elicits an autoimmune syndrome with pathology similar to graft-versus-host…”
Get full text

Specificity of effector T lymphocytes in autologous graft-versus-host disease : Role of the major histocompatibility complex class II invariant chain peptide by HESS, A. D, BRIGHT, E. C, THOBURN, C, VOGELSANG, G. B, JONES, R. J, KENNEDY, M. J

“…Administration of the immunosuppressive drug cyclosporine after autologous bone marrow transplantation induces a systemic autoimmune syndrome resembling…”
Get full text

Regulation of OX40 gene expression in graft-versus-host disease by Miura, Y., Thoburn, C.J., Bright, E.C., Arai, S., Hess, A.D.

“…OX40 (CD134), a member of the tumor necrosis factor receptor superfamily, is expressed on activated T cells, including CD4 +CD25 + T regulatory (Treg) cells…”
Get full text

Unexpected T-cell diversity in syngeneic graft-versus-host disease revealed by interaction with peptide-loaded soluble MHC class II molecules by HESS, Allan D, THOBURN, Christopher J, WEIRAN CHEN, BRIGHT, Emilie C

“…Administration of cyclosporine after syngeneic bone marrow transplantation elicits a systemic autoaggression syndrome termed syngeneic graft-versus-host…”
Get full text

Antigen-specific T-lymphocyte responses in acute and chronic syngeneic graft-versus-host disease by Hess, A.D., Thoburn, C.J., Miura, Y., Bright, E.C.

“…Administration of cyclosporine (CyA) following autologous bone marrow transplantation elicits a T-lymphocyte autoaggression syndrome with remarkable similarity…”
Get full text

Characterization of the autoreactive T cell repertoire in cyclosporin- induced syngeneic graft-versus-host disease. A highly conserved repertoire mediates autoaggression by Fischer, AC, Ruvolo, PP, Burt, R, Horwitz, LR, Bright, EC, Hess, JM, Beschorner, WE, Hess, AD

“…Syngeneic graft-vs-host disease (SGVHD) is a MHC class II-restricted T cell-mediated autoimmune syndrome that occurs following syngeneic bone marrow…”
Get full text

Characterization of peripheral autoregulatory mechanisms that prevent development of cyclosporin-induced syngeneic graft-versus-host disease by Hess, AD, Fischer, AC, Horwitz, L, Bright, EC, Laulis, MK

“…Administration of cyclosporin after syngeneic bone marrow transplantation paradoxically elicits a T lymphocyte-dependent autoaggression syndrome termed…”
Get full text

The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine by Hess, A D, Bright, E C

“…The effect of the CD28 activation pathway on the immunosuppressive action of CsA was assessed. Human peripheral blood lymphocytes were stimulated with…”
Get more information

Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand by Miura, Yuji, Thoburn, Christopher J., Bright, Emilie C., Hess, Allan D.

“…The administration of cyclosporin A (CsA) after autologous stem cell transplantation (SCT) paradoxically elicits a systemic autoimmune syndrome that resembles…”
Get full text

Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft-versus-host disease by Thoburn, Christopher J, Miura, Yuji, Bright, Emilie C, Hess, Allan D

“…Administration of cyclosporine after autologous bone marrow transplantation elicits a T-lymphocyte autoaggression syndrome with remarkable similarity to…”
Get full text

Immunological mechanisms governing tolerance to self-major histocompatibility complex antigens after bone marrow transplantation by Hess, A D, Fischer, A C, Horwitz, L R, Bright, E C, Hess, J M

Get more information

Drug-drug interaction between cyclosporine and agents affecting calcium-dependent lymphocyte proliferation by Colombani, P M, Bright, E C, Wells, M, Hess, A D

Get more information

Comparison of binding to peripheral blood lymphocytes between active and inactive derivatives of cyclosporine by Colombani, P M, Bright, E C, Hess, A D

Get more information

Subcellular action of cyclosporine: interaction between CsA and calmodulin antagonists by Colombani, P M, Bright, E C, Monastyrskyj, O, Hess, A D

Get more information